AI-powered medical search engine Vera Health, which says it is used by 800,000+ clinicians in 190 countries, raised a $28.5M Series A led by Threshold Ventures

Clinicians have a new, evidence-focused AI tool that prioritizes verifiable research over plausible answers.

Vera Health, an AI-powered medical search engine, has successfully closed a $28.5 million Series A funding round. The round was led by Threshold Ventures, with additional participation from Optum Ventures, Mantis VC, and SV Angel. Existing investors Y Combinator and Gradient also contributed to the funding. Vera Health's platform scans over 60 million peer-reviewed publications, clinical guidelines, and other medical resources to provide clinicians with evidence-based answers. The company reports that its tool is now used by more than 800,000 clinicians across 190 countries, experiencing significant growth from a few thousand users a year ago. The company intends to use the new capital to enhance its evidence infrastructure, support international expansion, forge new partnerships, and grow its team.

The substantial Series A funding for Vera Health underscores a growing investor appetite for AI solutions that directly address critical gaps in healthcare information dissemination. By focusing on "honesty, traceability, transparency and context," Vera Health aims to differentiate itself from more general-purpose AI language models that may generate plausible but unverified medical information. This approach, which prioritizes finding evidence before formulating an answer, could set a new standard for trust and reliability in clinical decision support tools.

Vera Health's rapid adoption by over 800,000 clinicians globally suggests a strong market demand for AI tools that can accelerate the integration of new medical knowledge into daily practice. The company's strategy to grow through clinician-to-clinician referrals, rather than a large sales force, indicates a product that is resonating deeply with its user base. Future developments will likely focus on further internationalizing its services and solidifying partnerships, potentially disrupting established medical information providers by offering a more dynamic and evidence-centric alternative.